These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 26239800

  • 1. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT.
    Li H, Song T, Qin Y, Liu W, Li X, Shao Y, Wen H.
    Parasitol Res; 2015 Nov; 114(11):4175-80. PubMed ID: 26239800
    [Abstract] [Full Text] [Related]

  • 2. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
    Kaltenbach TE, Graeter T, Mason RA, Kratzer W, Oeztuerk S, Haenle MM, Gruener B, Gottstein M.
    Nuklearmedizin; 2015 Nov; 54(1):43-9. PubMed ID: 25423884
    [Abstract] [Full Text] [Related]

  • 3. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
    Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA, Gabelmann A, Kern P, Kratzer W.
    Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
    [Abstract] [Full Text] [Related]

  • 4. Comparison of [18F]Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced Ultrasound for Evaluation of Hepatic Alveolar Echinococcosis Activity.
    Li J, Dong J, Yang L, Li X, Song T.
    Ultrasound Med Biol; 2018 Nov; 44(11):2199-2208. PubMed ID: 30077410
    [Abstract] [Full Text] [Related]

  • 5. Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial.
    Li H, Song T, Shao Y, Aili T, Ahan A, Wen H.
    Medicine (Baltimore); 2016 Jan; 95(4):e2237. PubMed ID: 26825878
    [Abstract] [Full Text] [Related]

  • 6. [Continuous albendazole therapy in alveolar echinococcosis--evaluation of therapeutic effect with computerized tomography and ultrasonography].
    Liu YH, Wang XG, Chen YT.
    Zhonghua Nei Ke Za Zhi; 1992 Dec; 31(12):761-3, 780. PubMed ID: 1306784
    [Abstract] [Full Text] [Related]

  • 7. [Continuous therapy with albendazole for hepatic alveolar echinococcosis associated with obstructive jaundice].
    Wang X, Liu Y, Yu D.
    Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):261-4. PubMed ID: 9387644
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.
    Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, Fischer DR, Müllhaupt B.
    PLoS Negl Trop Dis; 2015 Apr; 9(9):e0003964. PubMed ID: 26389799
    [Abstract] [Full Text] [Related]

  • 10. Albendazole therapy in human lung and liver hydatid cysts: A 13-year experience.
    Fattahi Masoom SH, Lari SM, Fattahi AS, Ahmadnia N, Rajabi M, NaderiKalat M.
    Clin Respir J; 2018 Mar; 12(3):1076-1083. PubMed ID: 28319358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
    Abulaihaiti M, Wu XW, Qiao L, Lv HL, Zhang HW, Aduwayi N, Wang YJ, Wang XC, Peng XY.
    PLoS Negl Trop Dis; 2015 Mar; 9(9):e0003950. PubMed ID: 26352932
    [Abstract] [Full Text] [Related]

  • 13. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
    Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, Deplazes P, von Schulthess GK, Muellhaupt B, Ammann RW, Renner EL.
    Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effect and safety of liposomal-albendazole and tablet-albendazole for the treatment of human cystic echinococcosis].
    Li HT, Shan JY, Shao YM, Tuergan A, Ayifuhan A, Ran B, Wen H.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):532-6. PubMed ID: 22152246
    [Abstract] [Full Text] [Related]

  • 15. Successful surgical management of hepatic alveolar echinococcosis by inductive therapy with albendazole - a case report.
    Bartels M, Schmidt T, Lübbert C.
    Z Gastroenterol; 2020 Jan; 58(1):63-67. PubMed ID: 31931542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.
    Fujimoto Y, Ito A, Ishikawa Y, Inoue M, Suzuki Y, Ohhira M, Ohtake T, Kohgo Y.
    J Gastroenterol; 2005 Apr; 40(4):426-31. PubMed ID: 15870979
    [Abstract] [Full Text] [Related]

  • 18. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY, Chen D, Zhang XS, Chen ZF, Hu AB.
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [Abstract] [Full Text] [Related]

  • 19. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
    Wen H, Zou PF, Yang WG, Lu J, Wang YH, Zhang JH, New RR, Craig PS.
    Trans R Soc Trop Med Hyg; 1994 Aug; 88(3):340-3. PubMed ID: 7974683
    [Abstract] [Full Text] [Related]

  • 20. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity.
    Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA, Bresson-Hadni S, Delabrousse E.
    Abdom Imaging; 2015 Jan; 40(1):56-63. PubMed ID: 24970734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.